A crowdfunding campaign is now LIVE on the INVESDOR platform

Together, let’s make Diamidex the future gold standard in industrial microbiological testing !

Our crowdfunding is live! Join our investors today and track the campaign in real time.

June 12 2025 - 6PM CET : Register for our DIAMIDEX live presentation and Q&A session

Keep me posted and get news about the fundraising!

8 + 10 =

5× Faster Results

With the same accuracy

Recurring Revenue Model

Proprietary consumables generate predictable cash-flow

Global Pull

Already 14 clients generating recurring revenues in 10 countries

Positive impact

Reduced sanitary risk & Destruction of Non-Compliant Products

Proven track record

Already trusted by global leaders in beverage, National and contract laboratories

Pre-Valuation: 12 M€
Amount sought up to 5 M€

Launching our flagship product in 2024 ....

Clients

Trial phases

6 bn€ Adressable Market(+10%/yr)

... with Early Adopters 

Testimonials

Being able to enumerate this pathogenic bacterium in only two days is a major step forward in the fight against such microbiological risk.

Dr. Beate Hambsch

Laboratory Manager, DVGW-Technologiezentrum Wasser

A method very reliable, suitable and comfortable to use for all, and most important a rapid proven test for the enumeration of Legionella pneumophila.

Dr Nissim Swissa

Laboratory Manager, Bactochem

To be a world-class company, one needs a world-class equipment - and this is where the Diamidex system comes in !

Pierre Voslchenk

Business Analyst, Summerpride